Article Details
Retrieved on: 2024-04-25 15:11:41
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses Kronos Bio Inc's stock market presence, with particular focus on the equity securities trading on NASDAQ. Corporate finance activities like Cerity Partners LLC's acquisition of shares and Acadian Asset Management's increase in stakes are highlighted. The fundamental analysis includes Kronos Bio's EPS, stock performance, and institutional investments.
Article found on: www.defenseworld.net
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here